Structure

Physi-Chem Properties

Molecular Weight:  528.16
Volume:  511.65
LogP:  3.762
LogD:  1.931
LogS:  -4.472
# Rotatable Bonds:  7
TPSA:  169.05
# H-Bond Aceptor:  11
# H-Bond Donor:  4
# Rings:  4
# Heavy Atoms:  11

MedChem Properties

QED Drug-Likeness Score:  0.218
Synthetic Accessibility Score:  4.322
Fsp3:  0.37
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.748
MDCK Permeability:  4.2476483940845355e-05
Pgp-inhibitor:  0.548
Pgp-substrate:  0.087
Human Intestinal Absorption (HIA):  0.698
20% Bioavailability (F20%):  0.0
30% Bioavailability (F30%):  0.802

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.018
Plasma Protein Binding (PPB):  90.36003875732422%
Volume Distribution (VD):  0.949
Pgp-substrate:  10.611763954162598%

ADMET: Metabolism

CYP1A2-inhibitor:  0.762
CYP1A2-substrate:  0.116
CYP2C19-inhibitor:  0.033
CYP2C19-substrate:  0.059
CYP2C9-inhibitor:  0.265
CYP2C9-substrate:  0.407
CYP2D6-inhibitor:  0.815
CYP2D6-substrate:  0.144
CYP3A4-inhibitor:  0.126
CYP3A4-substrate:  0.071

ADMET: Excretion

Clearance (CL):  0.993
Half-life (T1/2):  0.558

ADMET: Toxicity

hERG Blockers:  0.015
Human Hepatotoxicity (H-HT):  0.92
Drug-inuced Liver Injury (DILI):  0.982
AMES Toxicity:  0.608
Rat Oral Acute Toxicity:  0.026
Maximum Recommended Daily Dose:  0.382
Skin Sensitization:  0.818
Carcinogencity:  0.136
Eye Corrosion:  0.006
Eye Irritation:  0.177
Respiratory Toxicity:  0.735

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC474345

Natural Product ID:  NPC474345
Common Name*:   [(2S,3R,4S,5R,6S)-2-[(9-Acetyl-4,5-Dihydroxy-7-Methyl-10-Oxo-9H-Anthracen-2-Yl)Oxy]-3-Acetyloxy-5-Hydroxy-6-Methyloxan-4-Yl] Acetate
IUPAC Name:   [(2S,3R,4S,5R,6S)-2-[(9-acetyl-4,5-dihydroxy-7-methyl-10-oxo-9H-anthracen-2-yl)oxy]-3-acetyloxy-5-hydroxy-6-methyloxan-4-yl] acetate
Synonyms:  
Standard InCHIKey:  YCSCGCFLJRBNIA-NZFLMTEZSA-N
Standard InCHI:  InChI=1S/C27H28O11/c1-10-6-16-20(11(2)28)17-8-15(9-19(32)22(17)24(34)21(16)18(31)7-10)38-27-26(37-14(5)30)25(36-13(4)29)23(33)12(3)35-27/h6-9,12,20,23,25-27,31-33H,1-5H3/t12-,20?,23+,25-,26+,27-/m0/s1
SMILES:  CC(=O)O[C@H]1[C@H](Oc2cc(O)c3c(c2)C(C(=O)C)c2c(C3=O)c(O)cc(c2)C)O[C@H]([C@H]([C@@H]1OC(=O)C)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL465493
PubChem CID:   44567191
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0004603] Organic oxygen compounds
      • [CHEMONTID:0000323] Organooxygen compounds
        • [CHEMONTID:0000011] Carbohydrates and carbohydrate conjugates
          • [CHEMONTID:0002105] Glycosyl compounds
            • [CHEMONTID:0004165] Phenolic glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32935 rhamnus nepalensis Species Rhamnaceae Eukaryota Leaves Pa Co, Mai Chau, Hoa Binh Province, 150 km west of Hanoi, Vietnam 1995-Nov PMID[11575949]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT91 Cell Line KB Homo sapiens IC50 = 70.0 nM PMID[477099]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC474345 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9815 High Similarity NPC298778
0.9636 High Similarity NPC68381
0.9576 High Similarity NPC472054
0.9515 High Similarity NPC5029
0.9515 High Similarity NPC111536
0.9515 High Similarity NPC30432
0.9515 High Similarity NPC271385
0.9515 High Similarity NPC76128
0.9512 High Similarity NPC259905
0.9509 High Similarity NPC178851
0.9467 High Similarity NPC293227
0.9467 High Similarity NPC473631
0.9467 High Similarity NPC473717
0.9467 High Similarity NPC475662
0.9408 High Similarity NPC477860
0.9408 High Similarity NPC475161
0.9401 High Similarity NPC199533
0.9401 High Similarity NPC63105
0.9401 High Similarity NPC470454
0.9357 High Similarity NPC473686
0.9357 High Similarity NPC475220
0.9357 High Similarity NPC221140
0.9357 High Similarity NPC475352
0.9357 High Similarity NPC229817
0.9345 High Similarity NPC475246
0.9345 High Similarity NPC475233
0.9345 High Similarity NPC46958
0.9341 High Similarity NPC213052
0.9286 High Similarity NPC3718
0.9277 High Similarity NPC222455
0.9235 High Similarity NPC277710
0.9235 High Similarity NPC245059
0.9235 High Similarity NPC153578
0.9235 High Similarity NPC114257
0.9235 High Similarity NPC212290
0.9235 High Similarity NPC299149
0.9235 High Similarity NPC84494
0.9226 High Similarity NPC98776
0.9217 High Similarity NPC249977
0.9212 High Similarity NPC7752
0.9207 High Similarity NPC216752
0.9205 High Similarity NPC470193
0.9205 High Similarity NPC470198
0.9205 High Similarity NPC470194
0.9205 High Similarity NPC470197
0.9205 High Similarity NPC470196
0.9205 High Similarity NPC470200
0.9205 High Similarity NPC470195
0.9205 High Similarity NPC282474
0.9205 High Similarity NPC316274
0.9191 High Similarity NPC105591
0.9181 High Similarity NPC470453
0.9181 High Similarity NPC315221
0.9181 High Similarity NPC470452
0.9181 High Similarity NPC164047
0.9181 High Similarity NPC470448
0.9172 High Similarity NPC146803
0.9162 High Similarity NPC473202
0.9128 High Similarity NPC313452
0.9096 High Similarity NPC178281
0.9091 High Similarity NPC470199
0.9091 High Similarity NPC314459
0.9085 High Similarity NPC328093
0.9048 High Similarity NPC191653
0.9024 High Similarity NPC308265
0.9023 High Similarity NPC87583
0.9018 High Similarity NPC283480
0.9018 High Similarity NPC127406
0.9018 High Similarity NPC261866
0.9018 High Similarity NPC148323
0.9006 High Similarity NPC324220
0.9006 High Similarity NPC312630
0.9 High Similarity NPC85368
0.9 High Similarity NPC199357
0.8994 High Similarity NPC76047
0.8994 High Similarity NPC477571
0.8994 High Similarity NPC241874
0.8994 High Similarity NPC477573
0.8994 High Similarity NPC477572
0.8988 High Similarity NPC477502
0.8982 High Similarity NPC475979
0.8982 High Similarity NPC294722
0.8982 High Similarity NPC99216
0.8976 High Similarity NPC131745
0.8976 High Similarity NPC101116
0.8976 High Similarity NPC44947
0.8976 High Similarity NPC278329
0.8976 High Similarity NPC259834
0.8976 High Similarity NPC212099
0.8976 High Similarity NPC146837
0.897 High Similarity NPC472055
0.897 High Similarity NPC470358
0.897 High Similarity NPC472320
0.897 High Similarity NPC271479
0.8963 High Similarity NPC43638
0.8963 High Similarity NPC23817
0.8957 High Similarity NPC470603
0.8957 High Similarity NPC470604
0.8957 High Similarity NPC192219
0.8957 High Similarity NPC470605
0.8957 High Similarity NPC82190
0.8957 High Similarity NPC174599
0.8953 High Similarity NPC469600
0.8922 High Similarity NPC278419
0.8922 High Similarity NPC124155
0.8922 High Similarity NPC179198
0.8922 High Similarity NPC257566
0.8922 High Similarity NPC66087
0.8922 High Similarity NPC183672
0.8916 High Similarity NPC47923
0.8914 High Similarity NPC241847
0.8909 High Similarity NPC73511
0.8909 High Similarity NPC43761
0.8909 High Similarity NPC470339
0.8902 High Similarity NPC206378
0.8896 High Similarity NPC211158
0.8896 High Similarity NPC205172
0.8896 High Similarity NPC78021
0.8896 High Similarity NPC106625
0.8896 High Similarity NPC87304
0.8896 High Similarity NPC185103
0.8896 High Similarity NPC268950
0.8896 High Similarity NPC108706
0.8896 High Similarity NPC209393
0.8889 High Similarity NPC190217
0.8882 High Similarity NPC150767
0.8882 High Similarity NPC210808
0.8882 High Similarity NPC78734
0.8882 High Similarity NPC199079
0.8876 High Similarity NPC474024
0.8876 High Similarity NPC298847
0.8876 High Similarity NPC472622
0.887 High Similarity NPC314672
0.8862 High Similarity NPC97637
0.8862 High Similarity NPC190450
0.8862 High Similarity NPC472876
0.8862 High Similarity NPC187934
0.8862 High Similarity NPC300537
0.8862 High Similarity NPC127782
0.8862 High Similarity NPC473043
0.8855 High Similarity NPC470810
0.8851 High Similarity NPC208069
0.8851 High Similarity NPC265795
0.8848 High Similarity NPC208651
0.8848 High Similarity NPC257309
0.8848 High Similarity NPC161749
0.8848 High Similarity NPC197896
0.8848 High Similarity NPC206641
0.8848 High Similarity NPC313163
0.8848 High Similarity NPC258035
0.8848 High Similarity NPC470606
0.8848 High Similarity NPC156457
0.8841 High Similarity NPC39351
0.8841 High Similarity NPC26195
0.8841 High Similarity NPC27408
0.8841 High Similarity NPC99233
0.8841 High Similarity NPC95090
0.8841 High Similarity NPC72649
0.8841 High Similarity NPC97052
0.8841 High Similarity NPC169248
0.8837 High Similarity NPC469601
0.8837 High Similarity NPC470667
0.8834 High Similarity NPC273483
0.8834 High Similarity NPC259182
0.8834 High Similarity NPC87708
0.8834 High Similarity NPC121001
0.883 High Similarity NPC257011
0.883 High Similarity NPC137871
0.883 High Similarity NPC67134
0.883 High Similarity NPC9002
0.883 High Similarity NPC288152
0.883 High Similarity NPC472386
0.883 High Similarity NPC256760
0.883 High Similarity NPC47140
0.8827 High Similarity NPC214454
0.8827 High Similarity NPC477240
0.8827 High Similarity NPC106025
0.8824 High Similarity NPC470206
0.8824 High Similarity NPC470207
0.882 High Similarity NPC48474
0.882 High Similarity NPC264302
0.8817 High Similarity NPC5778
0.8817 High Similarity NPC207575
0.8817 High Similarity NPC236934
0.8817 High Similarity NPC13481
0.8817 High Similarity NPC70441
0.8817 High Similarity NPC472621
0.881 High Similarity NPC309025
0.881 High Similarity NPC243930
0.881 High Similarity NPC222936
0.881 High Similarity NPC121703
0.881 High Similarity NPC19709
0.881 High Similarity NPC88023
0.881 High Similarity NPC284960
0.881 High Similarity NPC29830
0.8802 High Similarity NPC477629
0.8802 High Similarity NPC159579
0.8802 High Similarity NPC48093
0.8802 High Similarity NPC101636
0.8802 High Similarity NPC216496

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC474345 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8848 High Similarity NPD4381 Clinical (unspecified phase)
0.8779 High Similarity NPD6559 Discontinued
0.8713 High Similarity NPD7804 Clinical (unspecified phase)
0.869 High Similarity NPD6959 Discontinued
0.8678 High Similarity NPD8312 Approved
0.8678 High Similarity NPD8313 Approved
0.8663 High Similarity NPD7074 Phase 3
0.8652 High Similarity NPD7879 Clinical (unspecified phase)
0.8614 High Similarity NPD8443 Clinical (unspecified phase)
0.8605 High Similarity NPD7054 Approved
0.8555 High Similarity NPD7472 Approved
0.8554 High Similarity NPD7819 Suspended
0.8545 High Similarity NPD7411 Suspended
0.8514 High Similarity NPD4338 Clinical (unspecified phase)
0.8512 High Similarity NPD7075 Discontinued
0.8506 High Similarity NPD6797 Phase 2
0.8497 Intermediate Similarity NPD5844 Phase 1
0.8488 Intermediate Similarity NPD7473 Discontinued
0.8485 Intermediate Similarity NPD4380 Phase 2
0.8457 Intermediate Similarity NPD7251 Discontinued
0.8443 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8439 Intermediate Similarity NPD3818 Discontinued
0.8421 Intermediate Similarity NPD6232 Discontinued
0.8409 Intermediate Similarity NPD7808 Phase 3
0.8343 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8333 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8324 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8324 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8324 Intermediate Similarity NPD6166 Phase 2
0.8324 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8274 Intermediate Similarity NPD1934 Approved
0.8274 Intermediate Similarity NPD6801 Discontinued
0.8263 Intermediate Similarity NPD8151 Discontinued
0.8229 Intermediate Similarity NPD7228 Approved
0.8204 Intermediate Similarity NPD3226 Approved
0.8191 Intermediate Similarity NPD7435 Discontinued
0.8182 Intermediate Similarity NPD2532 Approved
0.8182 Intermediate Similarity NPD2534 Approved
0.8182 Intermediate Similarity NPD2533 Approved
0.8166 Intermediate Similarity NPD37 Approved
0.814 Intermediate Similarity NPD6234 Discontinued
0.8129 Intermediate Similarity NPD4965 Approved
0.8129 Intermediate Similarity NPD4966 Approved
0.8129 Intermediate Similarity NPD4967 Phase 2
0.8128 Intermediate Similarity NPD6777 Approved
0.8128 Intermediate Similarity NPD6778 Approved
0.8128 Intermediate Similarity NPD6776 Approved
0.8128 Intermediate Similarity NPD6779 Approved
0.8128 Intermediate Similarity NPD6781 Approved
0.8128 Intermediate Similarity NPD6782 Approved
0.8128 Intermediate Similarity NPD6780 Approved
0.8083 Intermediate Similarity NPD7783 Phase 2
0.8083 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.8072 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.807 Intermediate Similarity NPD3817 Phase 2
0.8047 Intermediate Similarity NPD6599 Discontinued
0.8046 Intermediate Similarity NPD7199 Phase 2
0.8037 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.8033 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7989 Intermediate Similarity NPD5494 Approved
0.7989 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7975 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7975 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7965 Intermediate Similarity NPD5402 Approved
0.7964 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7938 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7938 Intermediate Similarity NPD7874 Approved
0.7927 Intermediate Similarity NPD1549 Phase 2
0.7919 Intermediate Similarity NPD7768 Phase 2
0.7907 Intermediate Similarity NPD8455 Phase 2
0.7907 Intermediate Similarity NPD1465 Phase 2
0.7907 Intermediate Similarity NPD2801 Approved
0.7906 Intermediate Similarity NPD7697 Approved
0.7906 Intermediate Similarity NPD7696 Phase 3
0.7906 Intermediate Similarity NPD7698 Approved
0.7904 Intermediate Similarity NPD6799 Approved
0.7882 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7882 Intermediate Similarity NPD7458 Discontinued
0.7879 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7874 Intermediate Similarity NPD3749 Approved
0.787 Intermediate Similarity NPD5403 Approved
0.7865 Intermediate Similarity NPD8320 Phase 1
0.7865 Intermediate Similarity NPD8319 Approved
0.7865 Intermediate Similarity NPD7870 Phase 2
0.7865 Intermediate Similarity NPD7871 Phase 2
0.7861 Intermediate Similarity NPD6535 Approved
0.7861 Intermediate Similarity NPD6534 Approved
0.7853 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7853 Intermediate Similarity NPD6823 Phase 2
0.7845 Intermediate Similarity NPD7240 Approved
0.7835 Intermediate Similarity NPD7701 Phase 2
0.7831 Intermediate Similarity NPD3750 Approved
0.7831 Intermediate Similarity NPD4628 Phase 3
0.7826 Intermediate Similarity NPD8150 Discontinued
0.7821 Intermediate Similarity NPD3751 Discontinued
0.7806 Intermediate Similarity NPD7801 Approved
0.7798 Intermediate Similarity NPD7390 Discontinued
0.7798 Intermediate Similarity NPD1511 Approved
0.7797 Intermediate Similarity NPD3787 Discontinued
0.7772 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7758 Intermediate Similarity NPD2346 Discontinued
0.7751 Intermediate Similarity NPD5401 Approved
0.7751 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7737 Intermediate Similarity NPD7699 Phase 2
0.7737 Intermediate Similarity NPD7700 Phase 2
0.7714 Intermediate Similarity NPD3882 Suspended
0.7706 Intermediate Similarity NPD1512 Approved
0.7697 Intermediate Similarity NPD2796 Approved
0.7697 Intermediate Similarity NPD5711 Approved
0.7697 Intermediate Similarity NPD5710 Approved
0.7665 Intermediate Similarity NPD6674 Discontinued
0.7661 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7636 Intermediate Similarity NPD1510 Phase 2
0.7636 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7622 Intermediate Similarity NPD1607 Approved
0.7619 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7619 Intermediate Similarity NPD6213 Phase 3
0.7619 Intermediate Similarity NPD6212 Phase 3
0.7619 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7602 Intermediate Similarity NPD7584 Approved
0.759 Intermediate Similarity NPD6099 Approved
0.759 Intermediate Similarity NPD6100 Approved
0.759 Intermediate Similarity NPD2935 Discontinued
0.759 Intermediate Similarity NPD1551 Phase 2
0.7554 Intermediate Similarity NPD7685 Pre-registration
0.7549 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.754 Intermediate Similarity NPD8434 Phase 2
0.753 Intermediate Similarity NPD3748 Approved
0.7515 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7514 Intermediate Similarity NPD1653 Approved
0.75 Intermediate Similarity NPD1240 Approved
0.75 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7456 Intermediate Similarity NPD2800 Approved
0.7426 Intermediate Similarity NPD7930 Approved
0.7425 Intermediate Similarity NPD2799 Discontinued
0.7423 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7405 Intermediate Similarity NPD5953 Discontinued
0.7403 Intermediate Similarity NPD7229 Phase 3
0.7399 Intermediate Similarity NPD6273 Approved
0.7387 Intermediate Similarity NPD7585 Approved
0.7385 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7384 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7381 Intermediate Similarity NPD5405 Approved
0.7381 Intermediate Similarity NPD5406 Approved
0.7381 Intermediate Similarity NPD5404 Approved
0.7381 Intermediate Similarity NPD5408 Approved
0.7378 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7378 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7356 Intermediate Similarity NPD920 Approved
0.7353 Intermediate Similarity NPD1243 Approved
0.7341 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7337 Intermediate Similarity NPD7583 Approved
0.7333 Intermediate Similarity NPD919 Approved
0.7333 Intermediate Similarity NPD8285 Discontinued
0.7326 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.731 Intermediate Similarity NPD7003 Approved
0.7306 Intermediate Similarity NPD4363 Phase 3
0.7306 Intermediate Similarity NPD4360 Phase 2
0.7305 Intermediate Similarity NPD6651 Approved
0.7297 Intermediate Similarity NPD7286 Phase 2
0.7289 Intermediate Similarity NPD4060 Phase 1
0.7286 Intermediate Similarity NPD7211 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD7680 Approved
0.7273 Intermediate Similarity NPD3268 Approved
0.7256 Intermediate Similarity NPD4908 Phase 1
0.7253 Intermediate Similarity NPD1247 Approved
0.7246 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7246 Intermediate Similarity NPD5124 Phase 1
0.7243 Intermediate Similarity NPD7177 Discontinued
0.7241 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7235 Intermediate Similarity NPD7266 Discontinued
0.7225 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7212 Intermediate Similarity NPD4625 Phase 3
0.7204 Intermediate Similarity NPD8059 Phase 3
0.7204 Intermediate Similarity NPD8058 Clinical (unspecified phase)
0.7191 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7186 Intermediate Similarity NPD1613 Approved
0.7186 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7176 Intermediate Similarity NPD2438 Suspended
0.7169 Intermediate Similarity NPD2313 Discontinued
0.7158 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7158 Intermediate Similarity NPD8127 Discontinued
0.7151 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD1933 Approved
0.7143 Intermediate Similarity NPD230 Phase 1
0.7118 Intermediate Similarity NPD7033 Discontinued
0.7114 Intermediate Similarity NPD7999 Approved
0.7081 Intermediate Similarity NPD3926 Phase 2
0.7069 Intermediate Similarity NPD6190 Approved
0.7066 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7066 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.7066 Intermediate Similarity NPD6798 Discontinued
0.7059 Intermediate Similarity NPD7799 Discontinued
0.7059 Intermediate Similarity NPD7097 Phase 1
0.7059 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7048 Intermediate Similarity NPD8366 Approved
0.7048 Intermediate Similarity NPD6832 Phase 2
0.7042 Intermediate Similarity NPD8469 Approved
0.7041 Intermediate Similarity NPD6355 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data